Company
EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| EYP-1901 | Phase 3 | Wet Age Related Macular Degeneration |
Latest
No recent events.
Follow EyePoint Pharmaceuticals, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.